Qing-xue Li

Title: Innovations of Qing-xue Li in Therapeutics Against HSV Infection

Introduction

Qing-xue Li is an accomplished inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of therapeutics, particularly in the fight against herpes simplex virus (HSV) infections. His innovative work has led to the development of novel compositions and methods that enhance the identification and testing of therapeutics.

Latest Patents

Qing-xue Li holds a patent for "Compositions and methods for identifying and testing therapeutics." This invention provides compositions and methods for identifying and testing therapeutics against HSV infection. It includes compositions comprising receptors that enable cell-specific entry of HSV. Additionally, the invention features a novel DNA sequence that encodes a protein B5T74, which allows HSV to infect and replicate in otherwise non-permissive cells. The patent also describes vectors that comprise isolated nucleic acids encoding HSV receptors, fragments of the HSV receptors, or homologs of the HSV receptor. Furthermore, it introduces a porcine cell system that expresses a herpes simplex virus receptor but does not express endogenous HSV entry receptors.

Career Highlights

Qing-xue Li is affiliated with the University of Michigan, where he continues to advance research in the field of virology and therapeutics. His work has garnered attention for its potential impact on treating HSV infections, which affect millions of individuals worldwide.

Collaborations

He has collaborated with notable colleagues, including Ning-hun C McLaren and Gangadharan Subramanian, to further enhance the research and development of therapeutic strategies against HSV.

Conclusion

Qing-xue Li's innovative contributions to the field of therapeutics against HSV infection highlight his dedication to advancing medical science. His patent and ongoing research at the University of Michigan represent significant strides in the fight against viral infections.